Viridian Therapeutics, Inc.\DE
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
Insider trades, last 90 days
0 buys · 1 sell
- Sold $348.19K
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
214
- −11 vs. Q1 2026
- Total value $2.5B
Superinvestors holding VRDN
0
- None of the superinvestors held VRDN at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by VRDN insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 20268:05 PM ET | Aug 19, 2026 | Tousignant JenniferChief Legal Officer | SSaleCommon Stock | −14.21K | $24.50 | −$348.19K | 0 | −100.0% | SEC |
| May 13, 20264:31 PM ET | May 11, 2026 | Fairmount Healthcare Fund II L.P. and 2 othersDirector, 10% Owner | PPurchaseCommon Stock | +1.18M | $17.00 | +$20M | 5.09M | +30.1% | SEC |
| Jan 2, 2026 | Dec 31, 2025 | Tousignant JenniferChief Legal Officer | SSaleCommon Stock | −2.27K | $31.16 | −$70.8K | 0 | −100.0% | SEC |
| Oct 27, 20254:30 PM ET | Oct 23, 2025 | Fairmount Healthcare Fund II L.P. and 2 othersDirector, 10% Owner | PPurchaseCommon Stock | +454.55K | $22.00 | +$10M | 3.91M | +13.1% | SEC |
| Sep 30, 2024 | Sep 27, 2024 | Beetham Thomas W.Chief Operating Officer | PPurchaseCommon Stock | +5K | $23.41 | +$117.05K | 6K | +500.0% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in VRDN at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 16,604,740 | $305.03M | 0.01% | +1,225,363+8.0% | Added |
| BlackRock, Inc. | 8,551,488 | $157.09M | 0.00% | +720,013+9.2% | Added |
| Bellevue Group AG | 6,731,909 | $123.67M | 2.60% | +5,765+0.1% | Added |
| Paradigm Biocapital Advisors LP | 6,723,788 | $123.52M | 2.31% | +3,574,895+113.5% | Added |
| Kynam Capital Management, LP | 6,453,877 | $118.56M | 6.55% | +4,112,225+175.6% | Added |